Meta-analysis shows sleep apnea linked to increased risk for sudden death, cardiovascular mortality
MONDAY, Aug. 9, 2021 (HealthDay News) — Obstructive sleep apnea (OSA) is a risk factor for all-cause mortality and cardiac mortality, according to a review recently published in BMJ Open Respiratory Research.
Emily S. Heilbrunn, from Penn State Health in Hershey, Pennsylvania, and colleagues conducted a systematic literature review and meta-analysis to estimate the risk for all-cause and cardiovascular mortality in individuals with OSA.
Based on 22 observational studies (42,099 participants), the researchers found that OSA was associated with all-cause sudden death (relative risk [RR], 1.74; 95 percent confidence interval [CI], 1.44 to 2.10) and cardiovascular mortality (RR, 1.94; 95 percent CI, 1.39 to 2.70). There was a marginally significant dose-response relationship between severity of OSA and the risk for death (P for interaction = 0.05): mild OSA (RR, 1.16; 95 percent CI, 0.70 to 1.93), moderate OSA (RR, 1.72; 95 percent CI, 1.11 to 2.67), and severe OSA (RR, 2.87; 95 percent CI, 1.70 to 4.85). Older age was a significant contributing factor in the relationship between OSA and mortality.
“This study highlights the importance of appropriate prevention measures to reduce the incidence of OSA and OSA-related sudden death,” Heilbrunn said in a statement. “Providing accessible and affordable treatments for populations with OSA may ultimately reduce adverse health outcomes for these individuals.”
Sleep-Disordered Breathing Affects Many Neonates With Myelomeningocele
Adenotonsillectomy Improves Growth in Children With Mild Sleep-Disordered Breathing
Hypoglossal Nerve Stimulation Aids Obstructive Sleep Apnea
Eli Lilly Says Zepbound Can Ease Obstructive Sleep Apnea
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions